Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Guideline-Based Eligibility According to clinical guidelines: A provider must rule out contraindications
Most compounding instructions default to this size because it carries the early titration cleanly
Nucleic Acids Res 32 , 143150 (2004)
Vandortuzumab vedotin (DSTP3086S, MSTP2109A, RG7450) is a humanized anti-STEAP1 IgG1 linked to MMAE that was evaluated in a phase I trial with 77 mCRPC patients 117
Consistent with the kinetic of ligand-induced GLP-1R internalization (Fig
US$ 28.01
US$ 20.67
US$ 22.25
US$ 21.91
.png&w=3840&q=75)
US$ 28.04
US$ 22.82
US$ 24.62
US$ 24.46
